FAQs

Why donate to Brave Bunny Fund?

It is more challenging to receive research grants for rare pediatric cancers because federal funders such as the National Institutes of Health (NIH) are typically more interested in funding health concerns affecting a broader population. As a result, researchers are reliant on the private sector for funding.

Your donation to Brave Bunny Fund allows the team at Cincinnati Children’s to continue answering questions about this disease such as Why is there an increase in children diagnosed with hepatoblastoma each year? What treatment options are most effective without harmful long-term effects? How can information learned about hepatoblastoma help treat other pediatric cancers?

Although hepatoblastoma (like all pediatric cancers) is uncommon, the rarity of the disease means nothing to the families it overwhelms.

Your donation is helping to progress doctors’ knowledge about the disease and optimize treatment plans for patient families in real time. Without such funding, this vital research could be delayed or aborted.

What is the impact of my donation and how will it be leveraged?

100% of your donation to Brave Bunny Fund, a registered 501(c)(3), goes directly to one of the five projects (listed in Purpose) at Cincinnati Children’s Hospital.

If you would like your donation to go to a specific project, please specify in the comments.

We are committed to leveraging every dollar raised and focused on obtaining a diverse array of donors. Brave Bunny Fund will match any donation amount up to $200K.

Accountability of funds?

Tom and Kristen have quarterly update calls with the team at Cincinnati Children’s during which they are apprised as to how the funds from Brave Bunny have been used for each of the projects. The team addresses any relevant discoveries or challenges that have arisen and expectations for the outcomes of each project. During these calls, potential future projects that Brave Bunny Fund can help support are also discussed.

Tom also maintains an open line of communication with Dr. Geller in which he informally updates Tom on the progression of the projects Brave Bunny Fund is committed to.

Tom and Kristen recently attended the hepatoblastoma patient family conference in Boston where they connected with other patient families, scientists and oncologists from around the world. The conference is held every three years and discusses recent research findings, novel therapies and current studies. The US patient registry that Brave Bunny Fund supports was presented to the group and received with great enthusiasm by patient families and doctors who identified the need for this resource years ago.

Where can I learn more about the team at Cincinnati Children’s?

Please refer to the Cincinnati Children’s website, or the links below for biographies on each of our dedicated team members:

Dr. Greg Tiao

Dr. James Geller

Dr. Nikolai Timchenko

Dr. Alexander Bondoc

Does Brave Bunny Fund host fundraising events?

Yes! Stay tuned. More information to come.